Effect of mycophenolate mofetil therapy on
inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Effect of sea buckthorn leaves on
inosine monophosphate and adenylocuccinatelyase gene expression in broilers during heat stress.
(3) Nonstandard abbreviations: AZA, azathioprine; TPMT, thiopurine methyltransferase; ITP, inosine triphosphate; ITPA, inosine triphosphate pyrophosphohydrolase; IMP,
inosine monophosphate; DTT, dithiothreitol; and CI, confidence interval.
Muscle
inosine monophosphate (IMP) content is an indicator meat flavor and adenylosuccinatelyase (ADSL) is a key enzymes regulating IMP synthesis.
Inosine triphosphatase (ITPA; EC 3.6.1.19) catalyzes the hydrolysis of ITP to
inosine monophosphate, thereby recycling purines that might otherwise be trapped in the form of ITP (1, 2).
A study by Kazeniac (1961) indicated that
inosine monophosphate (IMP) produced a major contribution to mouth satisfaction and had the effect of intensifying the flavor effects of other compounds.
In vitro investigations with recombinant human
inosine monophosphate dehydrogenase II-and phytohemagglutinin A-stimulated human peripheral blood mononuclear cells support the concept that the free fraction of MPA is the pharmacologically active form of the drug (6).
Various approaches have been proposed for the pharmacodynamic (PD) monitoring of immunosuppressants: One is evaluation of the activity of the specific target enzyme, such as calcineurin activity (CNA) for cyclosporin A (CsA) and tacrolimus (TRL) (3-5),
inosine monophosphate dehydrogenase for MMF (6-8), and P70S6 kinase activity for sirolimus (1, 9).
Effect of mycophenolic acid glucuronide on
inosine monophosphate dehydrogenase activity.
MMF is rapidly metabolized in vivo to its active constituent, mycophenolic acid (MPA), a reversible, noncompetitive inhibitor of
inosine monophosphate dehydrogenase.
Intracellularly, MP is converted by hypoxanthine guanine phosphorybosyltransferase into thioinosine monophosphate (TIMP) and subsequently into thioguanosine monophosphate by a two-step process involving
inosine monophosphate dehydrogenase and guanosine monophosphate synthetase (2).
MMF targets the de novo purine biosynthesis pathway by noncompetitive inhibition of
inosine monophosphate dehydrogenase, acting against the proliferation of T and B lymphocytes (1).